http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2541756-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a4dd2550557f794cee31e9bb6a019d80 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-145 |
| filingDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95aa4548d7dab128be9e492d477cff08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_481f5fee07759eef72c124a5eef3105e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0a0c6a360dcf6df7d30e4838bf619f5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbddf8f4cc4b56c09e2e4071c00e5abf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5127614059b5540eb95564e5d0ee75b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cb2316c029d8232d271e231db9f2bba |
| publicationDate | 2015-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2541756-C2 |
| titleOfInvention | Diagnostic technique for scleral support malfunction, accompanying myopia in children and adolescents |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to medicine, namely to ophthalmology, and can be used for diagnosing the scleral support malfunction, accompanying myopia in children and adolescents. That is ensured by stating joint hypermobility and/or platypodia and/or spinal curvature. The Kerdo index and the serum cortisol level are measured. If the patient is stated to suffer from joint hypermobility and/or platypodia and/or spinal curvature accompanied by the Kerdo index of more than 10% and the cortisol level of less than 250 nmole/l, the scleral support malfunction is diagnosed. n EFFECT: using no special expensive methods of analysis, the technique enables selecting the individual and adequate therapeutic approach in the given category of patients, particularly determining indications for the sclera-reinforcing intervention promoting the stabilisation of the myopia process. n 6 ex, 1 tbl |
| priorityDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.